Clinical Trial Update: Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments. [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial in advanced, metastatic, or unresectable soft tissue sarcoma that progressed after standard treatments has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: Italian Sarcoma Group | Conditions: Advanced Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED